<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00382903836406</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383640</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:47:27.808Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835102</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383510</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:10.392Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835379</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383537</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:10.352Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836413</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383641</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:10.123Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836420</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383642</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:10.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835409</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383540</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:10.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835393</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383539</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.936Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835386</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383538</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.804Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836482</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383648</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.784Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835362</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383536</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.749Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835171</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383517</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.729Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835188</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383518</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.694Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835164</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383516</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.675Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903836499</udiDi>
    <basicUdiDi>038290BTGFDFRO57</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383649</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835133</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383513</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.643Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835300</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383530</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.628Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835201</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383520</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.606Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835119</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383511</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.512Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835195</udiDi>
    <basicUdiDi>038290MCBLCMJW3C</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383519</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.493Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903835324</udiDi>
    <basicUdiDi>038290OZPDTPTEPP</basicUdiDi>
    <tradeName>Nexiva</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>383532</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T19:45:09.477Z</lastUpdated>
  </row>
</eudamedExport>